Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim, Young Hwan Koh, Bo Hyun Kim, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 3, pp. 603-612
Open Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

Hepatocellular carcinoma
Josep M. Llovet, Robin Kate Kelley, Augusto Villanueva, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 4382
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Amit G. Singal, Josep M. Llovet, Mark Yarchoan, et al.
Hepatology (2023) Vol. 78, Iss. 6, pp. 1922-1965
Open Access | Times Cited: 669
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 336
Management of Hepatocellular Carcinoma
Zachary J. Brown, Diamantis I. Tsilimigras, Samantha M. Ruff, et al.
JAMA Surgery (2023) Vol. 158, Iss. 4, pp. 410-410
Closed Access | Times Cited: 313
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Jian Zhou, Hui‐Chuan Sun, Zheng Wang, et al.
Liver Cancer (2023) Vol. 12, Iss. 5, pp. 405-444
Open Access | Times Cited: 176
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
Smith Apisarnthanarax, Aisling Barry, Minsong Cao, et al.
Practical Radiation Oncology (2021) Vol. 12, Iss. 1, pp. 28-51
Open Access | Times Cited: 138
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights
Diyang Xie, Kai Zhu, Zhenggang Ren, et al.
HepatoBiliary Surgery and Nutrition (2023) Vol. 12, Iss. 2, pp. 216-228
Open Access | Times Cited: 80
New concepts in the treatment of hepatocellular carcinoma
Sabrina Sidali, Eric Trépo, Olivier Sutter, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 7, pp. 765-774
Open Access | Times Cited: 71
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Bruno Sangro, Lorenza Rimassa, Maxime Ronot, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 17
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 100
Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
Shirley Lewis, Laura A. Dawson, Aisling Barry, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100498-100498
Open Access | Times Cited: 56
Outcome of No-Touch Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Multicenter Clinical Trial
Dong Ho Lee, Min Woo Lee, Pyo Nyun Kim, et al.
Radiology (2021) Vol. 301, Iss. 1, pp. 229-236
Closed Access | Times Cited: 55
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong‐Won Park
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 2, pp. 252-262
Open Access | Times Cited: 39
Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3–Expressing Liver Cancer by Immuno-PET
Stanley Fayn, Anna King, Nicholas T. Gutsche, et al.
Journal of Nuclear Medicine (2023) Vol. 64, Iss. 7, pp. 1017-1023
Open Access | Times Cited: 26
Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial
Zhongchao Li, Jing Liu, Bo Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
Chai Hong Rim, Jung Sue Lee, Soo‐Yeon Kim, et al.
JHEP Reports (2022) Vol. 5, Iss. 1, pp. 100594-100594
Open Access | Times Cited: 32
The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
Tomoki Kimura, Toshiki Fujiwara, Tsubasa Kameoka, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4383-4383
Open Access | Times Cited: 30
Recent advances in recurrent hepatocellular carcinoma therapy
Yuxue Gao, Qi-Qi Ning, Pengxiang Yang, et al.
World Journal of Hepatology (2023) Vol. 15, Iss. 4, pp. 460-476
Open Access | Times Cited: 16
Do We Have a Winner? Advocating for SBRT in HCC Management
Amir H. Safavi, Laura A. Dawson, Aruz Mesci
Clinical and Translational Radiation Oncology (2024) Vol. 45, pp. 100740-100740
Open Access | Times Cited: 5
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.
George Sgouros, Yuni K. Dewaraja, Freddy E. Escorcia, et al.
PubMed (2021) Vol. 62, Iss. Suppl 3, pp. 12S-22S
Closed Access | Times Cited: 40
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy
Zhu‐Jian Deng, Le Li, Yu‐Xian Teng, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 10, Iss. 1, pp. 147-158
Open Access | Times Cited: 35
Critical Analysis of the Updated Barcelona Clinic Liver Cancer (BCLC) Group Guidelines
Diamantis I. Tsilimigras, Hassan Aziz, Timothy M. Pawlik
Annals of Surgical Oncology (2022) Vol. 29, Iss. 12, pp. 7231-7234
Open Access | Times Cited: 27
The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis
Jianing Tang, Guo Long, Xuanxuan Li, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Tumor Response on Diagnostic Imaging after Proton Beam Therapy for Hepatocellular Carcinoma
Hikaru Niitsu, Masashi Mizumoto, Yinuo Li, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 357-357
Open Access | Times Cited: 4
Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Deepti Sharma, Divya Khosla, Babu Lal Meena, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102386-102386
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top